X

Clinical Trials

Contact Us

Head & Neck Cancer

EA3132 (NCT02734537) – RT credentialed at MBMC and Southeast, Cap Region pending

Phase II Randomized Trial of Adjuvant Radiotherapy With or Without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)


RTOG 0920 (NCT00956007) – RTOG Credentialing Required for Affiliate Sites Prior to Patient Registration

A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer


NRG-CC001 (NCT02360215)

A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases


MATCH: EAY131 (NCT02465050)

MATCH: Molecular analysis for therapy choice. Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors or lymphoma.